bispecific fully human monoclonal antibody (Innovent Biologics)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Namebispecific fully human monoclonal antibody (Innovent Biologics)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaPending

Originator CompaniesInnovent Biologics(Suzhou) Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesInnovent Biologics(Suzhou) Co Ltd

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A